These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 19321309)

  • 1. Basic symptoms in the general population and in psychotic and non-psychotic psychiatric adolescents.
    Meng H; Schimmelmann BG; Koch E; Bailey B; Parzer P; Günter M; Mohler B; Kunz N; Schulte-Markwort M; Felder W; Zollinger R; Bürgin D; Resch F
    Schizophr Res; 2009 Jun; 111(1-3):32-8. PubMed ID: 19321309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuated psychotic and basic symptom characteristics in adolescents with ultra-high risk criteria for psychosis, other non-psychotic psychiatric disorders and early-onset psychosis.
    Lo Cascio N; Saba R; Hauser M; Vernal DL; Al-Jadiri A; Borenstein Y; Sheridan EM; Kishimoto T; Armando M; Vicari S; Fiori Nastro P; Girardi P; Gebhardt E; Kane JM; Auther A; Carrión RE; Cornblatt BA; Schimmelmann BG; Schultze-Lutter F; Correll CU
    Eur Child Adolesc Psychiatry; 2016 Oct; 25(10):1091-102. PubMed ID: 26921232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between psychotic-like symptoms and neurocognitive performance in a general adolescent psychiatric sample.
    Lindgren M; Manninen M; Laajasalo T; Mustonen U; Kalska H; Suvisaari J; Moilanen K; Cannon TD; Huttunen M; Therman S
    Schizophr Res; 2010 Oct; 123(1):77-85. PubMed ID: 20729039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological evidence for abnormal neurodevelopment associated with early-onset psychoses.
    Bombin I; Mayoral M; Castro-Fornieles J; Gonzalez-Pinto A; de la Serna E; Rapado-Castro M; Barbeito S; Parellada M; Baeza I; Graell M; Payá B; Arango C
    Psychol Med; 2013 Apr; 43(4):757-68. PubMed ID: 22831788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schizophrenia risk factors constitute general risk factors for psychiatric symptoms in the population.
    Breetvelt EJ; Boks MP; Numans ME; Selten JP; Sommer IE; Grobbee DE; Kahn RS; Geerlings MI
    Schizophr Res; 2010 Jul; 120(1-3):184-90. PubMed ID: 20421160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transition and remission in adolescents at ultra-high risk for psychosis.
    Ziermans TB; Schothorst PF; Sprong M; van Engeland H
    Schizophr Res; 2011 Mar; 126(1-3):58-64. PubMed ID: 21095104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical impact of a positive family history of psychosis or mental illness in psychotic and non-psychotic mentally ill adolescents.
    Paruk S; Jhazbhay K; Singh K; Sartorius B; Burns JK
    J Child Adolesc Ment Health; 2017 Nov; 29(3):219-229. PubMed ID: 29092669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features.
    Yung AR; Phillips LJ; Yuen HP; McGorry PD
    Schizophr Res; 2004 Apr; 67(2-3):131-42. PubMed ID: 14984872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
    Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
    Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychotic symptoms and paranoid ideation in a population-based sample of 95-year-olds.
    Ostling S; Börjesson-Hanson A; Skoog I
    Am J Geriatr Psychiatry; 2007 Dec; 15(12):999-1004. PubMed ID: 18056818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of psychiatric comorbidity in individuals at Ultra High Risk of psychosis - Findings from the Longitudinal Youth at Risk Study (LYRIKS).
    Lim J; Rekhi G; Rapisarda A; Lam M; Kraus M; Keefe RS; Lee J
    Schizophr Res; 2015 May; 164(1-3):8-14. PubMed ID: 25818728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive growth charting in psychosis spectrum youths.
    Gur RC; Calkins ME; Satterthwaite TD; Ruparel K; Bilker WB; Moore TM; Savitt AP; Hakonarson H; Gur RE
    JAMA Psychiatry; 2014 Apr; 71(4):366-74. PubMed ID: 24499990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early detection of psychotic disorders in adolescents: specificity of basic symptoms in psychiatric patient samples.
    Resch F; Koch E; Möhler E; Parzer P; Brunner R
    Psychopathology; 2002; 35(5):259-66. PubMed ID: 12457016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adolescents and adults at clinical high-risk for psychosis: age-related differences in attenuated positive symptoms syndrome prevalence and entanglement with basic symptoms.
    Gerstenberg M; Theodoridou A; Traber-Walker N; Franscini M; Wotruba D; Metzler S; Müller M; Dvorsky D; Correll CU; Walitza S; Rössler W; Heekeren K
    Psychol Med; 2016 Apr; 46(5):1069-78. PubMed ID: 26671170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Putative psychotic symptoms in the Mexican American population: prevalence and co-occurrence with psychiatric disorders.
    Vega WA; Sribney WM; Miskimen TM; Escobar JI; Aguilar-Gaxiola S
    J Nerv Ment Dis; 2006 Jul; 194(7):471-7. PubMed ID: 16840842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Early detection of psychotic disorders].
    Schäfer MR; Klier CM; Papageorgiou K; Friedrich MH; Amminger GP
    Neuropsychiatr; 2007; 21(1):37-44. PubMed ID: 17555006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and clinical relevance of interview-assessed psychosis-risk symptoms in the young adult community.
    Schultze-Lutter F; Michel C; Ruhrmann S; Schimmelmann BG
    Psychol Med; 2018 May; 48(7):1167-1178. PubMed ID: 28889802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between processing speed and subclinical psychotic symptoms in the general population: focusing on sex differences.
    Rössler W; Ajdacic-Gross V; Müller M; Rodgers S; Kawohl W; Haker H; Hengartner MP
    Schizophr Res; 2015 Aug; 166(1-3):316-21. PubMed ID: 26070411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting psychosis in a general adolescent psychiatric sample.
    Lindgren M; Manninen M; Kalska H; Mustonen U; Laajasalo T; Moilanen K; Huttunen M; Cannon TD; Suvisaari J; Therman S
    Schizophr Res; 2014 Sep; 158(1-3):1-6. PubMed ID: 25015028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis.
    Velthorst E; Nieman DH; Becker HE; van de Fliert R; Dingemans PM; Klaassen R; de Haan L; van Amelsvoort T; Linszen DH
    Schizophr Res; 2009 Apr; 109(1-3):60-5. PubMed ID: 19272756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.